Sage Therapeutics's Earnings: A Preview

Sage Therapeutics SAGE is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Sage Therapeutics to report an earnings per share (EPS) of $-1.55.

Sage Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Performance in Previous Earnings

During the last quarter, the company reported an EPS missed by $0.04, leading to a 10.87% drop in the share price on the subsequent day.

Performance of Sage Therapeutics Shares

Shares of Sage Therapeutics were trading at $8.01 as of October 25. Over the last 52-week period, shares are down 57.32%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Sage Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.